NYSE · CIK 0000771999
DSS DSS, INC.
Insider trading from SEC Form 4. Last filing 33 d ago. Close $0.61 on Oct 9, 2026, +44% from the 52-week low and -58% from the high.
Last 90 days
Net insider value
-$18k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$18k by 1 insider
Insiders on file
1
with a Form 4 at this company
Price and insider trades, last year
DSSOct 9, 2026 · close 0.61
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at DSS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Heng Fai Ambrose Chan director, owner sell | $18k 21,852 shares | -2% | +102% from low-42% from high | |
| 46Moderate | Heng Fai Ambrose Chan director, owner buy | $1000k 1,025,746 shares | +33% | - |
Transactions
The last 4 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Heng Fai Ambrose Chan director, owner | SOpen-market sale Common Stock | -21,852 | $0.82 | $18k | 1,031,944 | 33 d ago |
| Feb 6, 2025 | Heng Fai Ambrose Chan director, owner | AGrant or award Common Stockindirect: See footnote | +1,000,000 | $0.00 | $0 | 1,002,978 | Feb 10, 2025 |
| Dec 10, 2024 | Heng Fai Ambrose Chan director, owner | POpen-market purchase Common Stockindirect: See footnote | +820,597 | $0.97 | $800k | 3,961,211 | Dec 12, 2024 |
| Dec 10, 2024 | Heng Fai Ambrose Chan director, owner | POpen-market purchase Common Stock | +205,149 | $0.97 | $200k | 1,184,475 | Dec 12, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Heng Fai Ambrose Chandirector, owner, ceo, officer, other
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.